Want to see TSE:APLI.H full AI Analyst Report?
Total Valuation
Appili Therapeutics Inc Class A has a market cap or net worth of C$1.32M. The enterprise value is C$15.17M.
Market CapC$1.32M
Enterprise ValueC$15.17M
Share Statistics
Appili Therapeutics Inc Class A has 132,366,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding132,366,120
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Appili Therapeutics Inc Class A’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count7
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Appili Therapeutics Inc Class A is ―. Appili Therapeutics Inc Class A’s PEG ratio is -0.00744.
PE Ratio―
PS Ratio7.60
PB Ratio-0.11
Price to FCF-1.34
Price to Operating Cash Flow―
PEG Ratio-0.00744
Income Statement
In the last 12 months, Appili Therapeutics Inc Class A had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Appili Therapeutics Inc Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.24
52-Week Price Change-60.00%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)45.90
Average Volume (3m)65.85K
Important Dates
Appili Therapeutics Inc Class A upcoming earnings date is Nov 12, 2026, After Close (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Appili Therapeutics Inc Class A as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Appili Therapeutics Inc Class A has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Appili Therapeutics Inc Class A EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Appili Therapeutics Inc Class A has ― in cash and marketable securities with C$13.33M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total DebtC$13.33M
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Appili Therapeutics Inc Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast249.12%
EPS Growth Forecast-93.09%